Cno Financial Group Stock Earnings Reports

CNO Financial Group reported a strong start to 2026 with operating EPS of $1.05, up 33% year-over-year (42% excluding prior significant items). The company delivered its 15th consecutive quarter of sales growth and continued agent-count expansion across both Consumer and Worksite divisions. Key operational highlights: total new annualized premiums (NAP) rose 11%; Consumer Life & Health NAP up 9% (with Medicare policies sold up 24% and Medicare supplement NAP up 53%); Worksite Life & Health NAP up 22% with strong growth in hospital indemnity and life products; annuity account values increased 7% and total client assets (including brokerage) rose to over $18 billion (up 12%). Investment income grew 6% year-over-year driven by asset growth and higher yields, supported by new-money rates above 6% for the 13th consecutive quarter. Capital remains strong (RBC inside target range, holding company liquidity $280M), and the company returned $77M to shareholders in the quarter (including $60M in buybacks). Management affirmed 2026 guidance while noting macro uncertainty and signaled likely upward revision of the three-year ROE target above the prior 12% waypoint in future guidance. Product-level notes: Medicare Supplement saw modestly adverse claims but management expects filed rate increases (effective 1/1/2026 and 7/1/2026 for different blocks) to materially improve benefit ratios by Q4; long-term care and traditional life experienced favorable experience; expense ratio was low in the quarter (18.9%) due to timing and expected to normalize over the year. Investment posture remains disciplined and high-quality, with $1.3B of new investments averaging ~5-year duration. Overall message: consistent, diversified growth, improving profitability, disciplined capital deployment, and ongoing investments in technology/AI to drive productivity and customer experience.